Titlebook: Renal Anemia; Conflicts and Contro Onyekachi Ifudu (Associate Professor of Medicine, Book 2002 Springer Science+Business Media Dordrecht 2

落后的煤渣

書目名稱Renal Anemia影響因子(影響力)




書目名稱Renal Anemia影響因子(影響力)學(xué)科排名




書目名稱Renal Anemia網(wǎng)絡(luò)公開度




書目名稱Renal Anemia網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Renal Anemia被引頻次




書目名稱Renal Anemia被引頻次學(xué)科排名




書目名稱Renal Anemia年度引用




書目名稱Renal Anemia年度引用學(xué)科排名




書目名稱Renal Anemia讀者反饋




書目名稱Renal Anemia讀者反饋學(xué)科排名

俗艷

Insul島

ellagic-acid

Clinton D. Brown,Zhong H. Zhao,Lorraine L. Thomas,Robert deGroof,Eli A. Friedman

etiquette

Onyekachi Ifudu (Associate Professor of Medicine,

小教堂

Is long-term intravenous iron therapy risky?,Cs also contributed to iron overloading in the past and was associated with iron deposits in liver reticuloendothelial and parenchymal cells. However, iron overloading was not associated with functional changes in the liver (i.e., increases in liver function tests or cirrhosis) unless PRBC transfusions resulted in viral hepatitis [1].

包租車船

bronchiole

Normalizing hematocrit in renal failure: dangerous or desirable?, or fully corrected is arguably the most debated and controversial issue in this aspect of patient management. Why is this so? If one examines the scientific evidence relating to this topic, one can find both circumstantial evidence, and also evidence from intervention clinical trials [4–11].

Suggestions

山頂可休息

Epilogue,traordinary impact of treatment with erythropoietin in functionally anephric peritoneal dialysis and hemodialysis patients, Ifudu convened diverse professionals with shared interest in the uremic patient and concentrated their attention on the remarkable positive change in rehabilitation potential imparted by recombinant erythropoietin.